ABSTRACT
The thrust of this chapter focuses on testing methods and requirements for particulate matter in sterile products. Some coverage on increasing concerns about the effect of particles (especially subvisible) on biopharmaceutical product safety and quality will supplement what was presented in Chapter 8.
